25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Gastrointestinal microbiota may be involved in Helicobacter pylori-associated gastric cancer development. The aim of this study was to explore the possible microbial mechanisms in gastric carcinogenesis and potential dysbiosis arising from H. pylori infection.

          Design

          Deep sequencing of the microbial 16S ribosomal RNA gene was used to investigate alterations in paired gastric biopsies and stool samples in 58 subjects with successful and 57 subjects with failed anti- H. pylori treatment, relative to 49 H. pylori negative subjects.

          Results

          In H. pylori positive subjects, richness and Shannon indexes increased significantly (both p<0.001) after successful eradication and showed no difference to those of negative subjects (p=0.493 for richness and p=0.420 for Shannon index). Differential taxa analysis identified 18 significantly altered gastric genera after eradication. The combination of these genera into a Microbial Dysbiosis Index revealed that the dysbiotic microbiota in H. pylori positive mucosa was associated with advanced gastric lesions (chronic atrophic gastritis and intestinal metaplasia/dysplasia) and could be reversed by eradication. Strong coexcluding interactions between Helicobacter and Fusobacterium, Neisseria, Prevotella, Veillonella, Rothia were found only in advanced gastric lesion patients, and were absent in normal/superficial gastritis group. Changes in faecal microbiota included increased Bifidobacterium after successful H. pylori eradication and more upregulated drug-resistant functional orthologs after failed treatment.

          Conclusion

          H. pylori infection contributes significantly to gastric microbial dysbiosis that may be involved in carcinogenesis. Successful H. pylori eradication potentially restores gastric microbiota to a similar status as found in uninfected individuals, and shows beneficial effects on gut microbiota.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

          The Sydney System for the classification of gastritis emphasized the importance of combining topographical, morphological, and etiological information into a schema that would help to generate reproducible and clinically useful diagnoses. To reappraise the Sydney System 4 years after its introduction, a group of gastrointestinal pathologists from various parts of the world met in Houston, Texas, in September 1994. The aims of the workshop were (a) to establish an agreed terminology of gastritis; (b) to identify, define, and attempt to resolve some of the problems associated with the Sydney System. This article introduces the Sydney System as it was revised at the Houston Gastritis Workshop and represents the consensus of the participants. Overall, the principles and grading of the Sydney System were only slightly modified, the grading being aided by the provision of a visual analogue scale. The terminology of the final classification has been improved to emphasize the distinction between the atrophic and nonatrophic stomach; the names used for each entity were selected because they are generally acceptable to both pathologists and gastroenterologists. In addition to the main categories and atrophic and nonatrophic gastritis, the special or distinctive forms are described and their respective diagnostic criteria are provided. The article includes practical guidelines for optimal biopsy sampling of the stomach, for the use of the visual analogue scales for grading the histopathologic features, and for the formulation of a comprehensive standardized diagnosis. A glossary of gastritis-related terms as used in this article is provided.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome

            Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer. However, the long-term consequences of this treatment on the human indigenous microbiota are relatively unexplored. Here we studied short- and long-term effects of clarithromycin and metronidazole treatment, a commonly used therapy regimen against H. pylori, on the indigenous microbiota in the throat and in the lower intestine. The bacterial compositions in samples collected over a four-year period were monitored by analyzing the 16S rRNA gene using 454-based pyrosequencing and terminal-restriction fragment length polymorphism (T-RFLP). While the microbial communities of untreated control subjects were relatively stable over time, dramatic shifts were observed one week after antibiotic treatment with reduced bacterial diversity in all treated subjects in both locations. While the microbiota of the different subjects responded uniquely to the antibiotic treatment some general trends could be observed; such as a dramatic decline in Actinobacteria in both throat and feces immediately after treatment. Although the diversity of the microbiota subsequently recovered to resemble the pre treatment states, the microbiota remained perturbed in some cases for up to four years post treatment. In addition, four years after treatment high levels of the macrolide resistance gene erm(B) were found, indicating that antibiotic resistance, once selected for, can persist for longer periods of time than previously recognized. This highlights the importance of a restrictive antibiotic usage in order to prevent subsequent treatment failure and potential spread of antibiotic resistance.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994.

                Bookmark

                Author and article information

                Journal
                Gut
                Gut
                gutjnl
                gut
                Gut
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0017-5749
                1468-3288
                September 2020
                19 December 2019
                : 69
                : 9
                : 1598-1607
                Affiliations
                [1 ] departmentKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology , Peking University Cancer Hospital & Institute , Beijing, China
                [2 ] departmentPYLOTUM Key joint laboratory for upper GI cancer , Technische Universität München/Peking University Cancer Hospital & Institute , Munich/Beijing, Germany/China
                [3 ] departmentInstitute of Medical Microbiology, Immunology and Hygiene , Technische Universität München , Munich, Germany
                [4 ] departmentGerman Center for Infection Research , Partner Site Munich , Munich, Germany
                [5 ] departmentInstitute of Pathology , Klinikum Bayreuth , Bayreuth, Germany
                [6 ] departmentII. Medizinische Klinik, Klinikum Rechts der Isar , Technische Universität München , Munich, Germany
                [7 ] departmentDepartment of Medicine, 1st Faculty of Medicine , Military University Hospital, Charles University , Prague, Czech Republic
                [8 ] Linqu Public Health Bureau , Linqu, Shandong, China
                [9 ] Institute of Medical Informatics, Statistics and Epidemiology, Technische Universität München , Munich, Germany
                Author notes
                [Correspondence to ] Dr Kai-Feng Pan, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing 100142, China; pankaifeng2002@ 123456yahoo.com ; Dr Wei-Cheng You, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing 100142, China; weichengyou@ 123456yahoo.com
                Author information
                http://orcid.org/0000-0002-8209-819X
                http://orcid.org/0000-0002-8497-582X
                Article
                gutjnl-2019-319696
                10.1136/gutjnl-2019-319696
                7456744
                31857433
                b6803072-ee00-430e-910f-d49c53ed820a
                © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 22 August 2019
                : 06 November 2019
                : 10 December 2019
                Funding
                Funded by: International (regional) Cooperation and Exchange Project (NSFC-DFG);
                Award ID: 81861138041
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81572811
                Funded by: Beijing Municipal Administration of Hospitals’ Ascent Plan;
                Award ID: DFL20181102
                Funded by: German Research Foundation (DFG);
                Award ID: SFB 1371
                Funded by: German Federal Ministry of Education and Research (BMBF);
                Award ID: 01DO17022
                Funded by: National Key R&D Program of China;
                Award ID: 2018YFC1313105
                Categories
                Gut Microbiota
                1506
                2312
                Original research
                Custom metadata
                unlocked

                Gastroenterology & Hepatology
                helicobacter pylori - treatment,gastric diseases,gastric pre-cancer,bacterial interactions

                Comments

                Comment on this article